MX168927B - METHOD FOR THE PREPARATION OF CELLS RESISTANT TO INFECTION OVERLAYS OR LYMPHOTROPIC T-CELL VIRUSES - Google Patents

METHOD FOR THE PREPARATION OF CELLS RESISTANT TO INFECTION OVERLAYS OR LYMPHOTROPIC T-CELL VIRUSES

Info

Publication number
MX168927B
MX168927B MX2694687A MX2694687A MX168927B MX 168927 B MX168927 B MX 168927B MX 2694687 A MX2694687 A MX 2694687A MX 2694687 A MX2694687 A MX 2694687A MX 168927 B MX168927 B MX 168927B
Authority
MX
Mexico
Prior art keywords
infection
lymphotropic
overlays
preparation
cell viruses
Prior art date
Application number
MX2694687A
Other languages
Spanish (es)
Inventor
William A Carter
Original Assignee
William A Carter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William A Carter filed Critical William A Carter
Priority to MX2694687A priority Critical patent/MX168927B/en
Publication of MX168927B publication Critical patent/MX168927B/en

Links

Abstract

La presente invención se refiere a método para hacer celulas o fluido biológico resistentes a infección con retrovirus o virus lifotrópico de células T, porejemplo el virus del SIDA, mejorando su resistencia o mitigando el efecto de la infeción del mismo, caracterizado porque comprende mezclar o poner en contacto el fluido biológico o células con una cantidad efectiva de ácido ribonucléico de doble hebra(dhARN/dsRNA).The present invention relates to a method for making cells or biological fluid resistant to infection with retroviruses or lifotropic T-cell viruses, for example the AIDS virus, improving their resistance or mitigating the effect of infection thereof, characterized in that it comprises mixing or putting by contacting the biological fluid or cells with an effective amount of double stranded ribonucleic acid (dhRNA / dsRNA).

MX2694687A 1987-03-09 1987-03-09 METHOD FOR THE PREPARATION OF CELLS RESISTANT TO INFECTION OVERLAYS OR LYMPHOTROPIC T-CELL VIRUSES MX168927B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2694687A MX168927B (en) 1987-03-09 1987-03-09 METHOD FOR THE PREPARATION OF CELLS RESISTANT TO INFECTION OVERLAYS OR LYMPHOTROPIC T-CELL VIRUSES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2694687A MX168927B (en) 1987-03-09 1987-03-09 METHOD FOR THE PREPARATION OF CELLS RESISTANT TO INFECTION OVERLAYS OR LYMPHOTROPIC T-CELL VIRUSES

Publications (1)

Publication Number Publication Date
MX168927B true MX168927B (en) 1993-06-14

Family

ID=19742769

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2694687A MX168927B (en) 1987-03-09 1987-03-09 METHOD FOR THE PREPARATION OF CELLS RESISTANT TO INFECTION OVERLAYS OR LYMPHOTROPIC T-CELL VIRUSES

Country Status (1)

Country Link
MX (1) MX168927B (en)

Similar Documents

Publication Publication Date Title
Ashutosh et al. Molecular mechanisms of antimony resistance in Leishmania
Li et al. Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir
Ganesh et al. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies
Frank et al. Lysophosphatidyl choline facilitates labeling of CNS projections with horseradish peroxidase
Hiraragi et al. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II is required for viral infectivity in vivo
DE60023300D1 (en) USE OF CPG AS ADJUVANS FOR HIV PULP
AR013230A1 (en) TARGET CYTOLYSIS OF WHITE CELLS, AGENTS AND COMPOUNDS THAT CAUSE IT AND COMPOUNDS THAT CAN BE USED TO PRODUCE SUCH AGENTS
Calvignac-Spencer et al. Origin of human T-lymphotropic virus type 1 in rural Cote d’Ivoire
FR2731013B1 (en) GROUP O HIV-1, FRAGMENTS OF SAID VIRUSES, AND THEIR APPLICATIONS
Sheremata et al. Association of ‘(tropical) ataxic neuropathy’with HTLV-II
FR3097433B1 (en) COMPOSITION CONSISTING OF AT LEAST ONE COPOLYMER OF AMPS®, AT LEAST ONE ACYL GLUTAMIC ACID OR ONE OF ITS SALTS AND AT LEAST ONE ALKYLPOLYGLUCOSIDE
JPS56122835A (en) Manufacture of waterrsoluble nitrogenncontaining condensated product and its use in pulping
ES2010727A6 (en) Monoclonal antibodies to HIV and related peptides
D'Agostino et al. The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth
Roesch et al. Vpr enhances tumor necrosis factor production by HIV-1-infected T cells
Daussy et al. HIV-1 Env induces pexophagy and an oxidative stress leading to uninfected CD4+ T cell death
DE3780016D1 (en) PHARMACEUTICAL PREPARATION WITH 3'-DESOXYTHYMIDIN-2'-EN (3'-DESOXY-2 ', 3'-DIDEHYDROTHYMIDINE) FOR TREATING PATIENTS WITH RETROVIRAL INFECTIONS.
DE3882078D1 (en) AMPEROMETRIC METHOD FOR TITRATION OF NADH (1,4-DIHYDRONICOTINAMIDE-ADENINE-DINUCLEOTIDE) IN SOLUTION.
Nobre et al. Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin
DK577181A (en) MUSCLE POLYPEPTIME FRACTIONS
MX168927B (en) METHOD FOR THE PREPARATION OF CELLS RESISTANT TO INFECTION OVERLAYS OR LYMPHOTROPIC T-CELL VIRUSES
BRPI9713891A (en) "In vitro diagnostic method of a non-m, non-o, hiv-1 virus and, selection and typing method of a non-m, non-o hiv-1 virus"
WO1990013281A3 (en) Method of suppressing hiv infection
Giese et al. The nef protein of the macrophage tropic HIV-1 strain AD8 counteracts human BST-2/Tetherin
MELLERT et al. Inhibition of HIV-1 replication by an antiviral xanthate compound in vitro